Actuate Therapeutics Inc
ACTU | NASDAQ
$0.89
-$0.02 (-1.91%)
Sep 22, 2026, 1:10 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 4.43M | 8.13M | 13.16M | 16.92M | 6.49M | 3.89M | 8.64M | 13.52M | 351.71K | 2.07M | 2.96M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 451.4K | 391.84K | 392.49K | 269.93K | 280.34K | 234.48K | 110.55K | n/a | 1.18M | 510.5K | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 322.1K | 385.44K | 484K | n/a | 0 | 359.16K | 0 | 739.33K | 197.98K | 119.77K | 36.91K |
Total Current Assets | 4.75M | 8.52M | 13.64M | 17.44M | 6.69M | 4.25M | 9.21M | 14.26M | 549.69K | 2.19M | 3M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 451.4K | 391.84K | 392.49K | 269.93K | 280.34K | 234.48K | 110.55K | n/a | 1.18M | 510.5K | n/a |
Total Assets | 5.2M | 8.91M | 14.04M | 17.71M | 6.97M | 4.48M | 9.32M | 14.26M | 1.73M | 2.7M | 3M |
Account Payables | 1.08M | 1.2M | 1.52M | 1.25M | 3.17M | 2.64M | 1.92M | 2.33M | 5.89M | 3.96M | 3.42M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.9M | 5M | n/a |
Other Current Liabilities | 2.73M | 3.52M | 3.59M | 846.28K | 0 | 1.24M | 0 | n/a | 277.5K | 277.5K | 277.5K |
Total Current Liabilities | 3.81M | 4.72M | 5.71M | 6.37M | 9.2M | 9.15M | 8.8M | 8.5M | 20.07M | 14.73M | 6.92M |
Long-Term Debt | 404.99K | 404.99K | 404.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 404.99K | 421.88K | 416.82K | 411.76K | 406.68K | 95.91M | 95.74M | 95.7M |
Total Long-Term Liabilities | 404.99K | 404.99K | 404.99K | 404.99K | 421.88K | 416.82K | 411.76K | 406.68K | 95.91M | 95.74M | 95.7M |
Total Liabilities | 4.21M | 5.13M | 6.11M | 6.78M | 9.62M | 9.57M | 9.21M | 8.9M | 115.99M | 110.47M | 102.62M |
Total Debt | 404.99K | 404.99K | 404.99K | n/a | n/a | n/a | n/a | n/a | 6.9M | 5M | n/a |
Book Value | 989.15K | 3.78M | 7.92M | 10.94M | -2.65M | -5.09M | 104.19K | 5.36M | -114.26M | -107.77M | -99.63M |
Book Value Per Share | 0.04 | 0.16 | 0.34 | 0.51 | -0.14 | -0.26 | 0.01 | 0.27 | -5.85 | -6.96 | -6.53 |
Common Stock | 24 | 24 | 23 | 23 | 20 | 20 | 20 | 20 | 2 | 2 | 2 |
Retained Earnings | -165.1M | -160.23M | -154.61M | -150.05M | -144.65M | -138.7M | -132.38M | -125.93M | -119.96M | -113.39M | -105.09M |
Comprehensive Income | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 989.15K | 3.78M | 7.92M | 10.94M | -2.65M | -5.09M | 104.19K | 5.36M | -114.26M | -107.77M | -99.63M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ACTU